WDC
74
4
BBY
41
4
VNO
51
-3
O
51
-4
GT
23
3
MAR
65
3
SYK
50
4
APH
77
10
AMT
45
2
SE
71
6
NTAP
67
2
ETN
76
3
UHS
58
2
HUM
39
-2
PPL
70
-2
PCAR
43
9
DOV
53
3
MO
54
-2
FIS
65
2
PEP
26
6
WDC
74
4
BBY
41
4
VNO
51
-3
O
51
-4
GT
23
3
MAR
65
3
SYK
50
4
APH
77
10
AMT
45
2
SE
71
6
NTAP
67
2
ETN
76
3
UHS
58
2
HUM
39
-2
PPL
70
-2
PCAR
43
9
DOV
53
3
MO
54
-2
FIS
65
2
PEP
26
6
Financhill
Back

First Trust NASDAQ Technology Dividend Index Fund Vs. Akero Therapeutics Industry Stock Comparison

Buy
80

TDIV
First Trust NASDAQ Technology Dividend Index Fund

Last Price:
$88.86
Seasonality Move:
1.46%
Buy
51

AKRO
Akero Therapeutics

Last Price:
$55.06
Seasonality Move:
30.3%
Buy
80
First Trust NASDAQ Technology Dividend Index Fund (TDIV) is a Buy

Is First Trust NASDAQ Technology Dividend Index Fund a Buy, Sell or Hold?

  • The current First Trust NASDAQ Technology Dividend Index Fund [TDIV] share price is $89.10. The Score for TDIV is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TDIV is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $53.92. The Score for AKRO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TDIV Stock Price Chart

What is First Trust NASDAQ Technology Dividend Index Fund's stock price today?

  • The First Trust NASDAQ Technology Dividend Index Fund share price today is $89.10
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TDIV is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $53.92
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.

TDIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.28 Buy
Relative Strength Index (14 RSI): 74.51 Buy
Chaikin Money Flow: 68613 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (81.43 - 86.49) Buy
Bollinger Bands (100): (72.72 - 83.68) Buy

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.56 Buy
Relative Strength Index (14 RSI): 61.7 Buy
Chaikin Money Flow: -1344142 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.05 - 55.47) Buy
Bollinger Bands (100): (40.1 - 52.22) Buy

TDIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 86.88 Buy
20-day SMA: 84.7 Buy
50-day SMA: 79.05 Buy
200-day SMA: 78.93 Buy
8-day EMA: 86.81 Buy
20-day EMA: 84.81 Buy
50-day EMA: 81.27 Buy
200-day EMA: 77.77 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.67 Sell
20-day SMA: 52.61 Buy
50-day SMA: 45.94 Buy
200-day SMA: 37.63 Buy
8-day EMA: 54.22 Sell
20-day EMA: 52.25 Buy
50-day EMA: 48.11 Buy
200-day EMA: 39.5 Buy

First Trust NASDAQ Technology Dividend Index Fund Earnings Growth & TDIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

First Trust NASDAQ Technology Dividend Index Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):